Morgan Stanley reports vesting of 10,075 ATOM shares

Morgan Stanley Smith Barney LLC Executive Financial Services reported the vesting of 10,075 shares of Common stock under the issuer's equity compensation plan with dates shown 03/01/2026 and 03/02/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services reported the vesting of 10,075 shares of Common stock under the issuer's equity compensation plan with dates shown 03/01/2026 and 03/02/2026.

The filing lists this vesting alongside a Form 144 securities‑to‑be‑sold entry for Common stock on 03/02/2026; the shares were granted as part of the issuer's equity compensation plan.

Insights

Compensation Analyst

Vesting recorded for 10,075 common shares under equity compensation.

The excerpt documents the vesting of 10,075 Common shares on 03/01/2026–03/02/2026

This reflects plan‑based issuance: the shares are shown as "Granted as part of issuer's equity compensation plan," and a Form 144 entry appears for planned resale. Timing and sale treatment are limited to the dates displayed; subsequent filings would show actual sales.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for ATOM show about the shares?

The filing shows the vesting of 10,075 Common shares tied to the issuer's equity compensation plan, with dates 03/01/2026 and 03/02/2026. It also lists a Form 144 securities‑to‑be‑sold entry on 03/02/2026.

Who is the filer listed on the ATOM Form 144 excerpt?

The filer is identified as Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY. The filing references transactions in ATOM Common stock on 03/02/2026.

Are the vested shares from an equity compensation plan?

Yes. The excerpt explicitly states the shares were "Granted as part of issuer's equity compensation plan" and notes the event as a "Vesting of Restricted Stock" with dates shown in March 2026.

Does the excerpt show proceeds or sale execution details?

No. The excerpt lists a Form 144 securities‑to‑be‑sold entry but does not provide sale proceeds, prices, or execution details; it only shows the vesting and the Form 144 entry dated 03/02/2026.

How many shares are associated with the filing for ATOM?

The filing lists 10,075 shares of Common stock in connection with the vesting and Form 144 entries, with the relevant dates shown as 03/01/2026 and 03/02/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 09:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001464249
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Atomera, Inc.
SEC File Number	001-37850
Address of Issuer	750 University Avenue, Suite 280 Los Gatos CALIFORNIA 95032
Phone	408-442-5248
Name of Person for Whose Account the Securities are To Be Sold	Scott Bibaud
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10075	49859.54	38696147	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2026	Vesting of Restricted Stock	Issuer			10075	03/02/2026	Granted as part of issuer's equity compensation plan.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares are being sold pursuant to "sell to cover" transactions under four separate compensatory equity awards with distinct grant dates of 2/23/22, 2/23/23, 2/21/24 and 2/19/25. Each award agreement includes a provision for non-discretionary "sell-to-cover transactions" pursuant to Rule 10b5-1(c)(1)(ii)(D)(3) under the Exchange Act and each award is intended to operate as a "Rule 10b5-1 trading arrangement" as the term is defined in Item 408(a) of Regulation S-K.
Date of Notice	03/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Scott Bibaud
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)